Drug Approval

Drug Approvals Reached New High in 2014: What's Next?

Medicine & Technology Approvals for medicine in the United States have reached their highest levels in eighteen years, and recommendations for new drugs in Europe also came at a rapid rate, driven by expensive new treatments for cancer and other rare and serious diseases. After enduring wave after wave of patent losses on some of their larger, more popular drugs, pharmaceutical firms are beginning to recover by bringing new medicines to the market, while also improving their productivity.
Most Popular

Recommended Stories

Real Time Analytics